Quarterly report pursuant to Section 13 or 15(d)

Fair Value Measurements and Hierarchy - Changes in Fair Value (Details)

v3.24.3
Fair Value Measurements and Hierarchy - Changes in Fair Value (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation        
Ending balance $ 19,296 $ 51 $ 19,296 $ 51
Gain from change in fair value of warrant liability (5,737) (755) (14,626) 327
Medcore Health Plan, Inc and Omni IPA Medical Group, Inc        
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation        
Gain on write off of contingent consideration (6,200)   (6,200)  
Private Placement Warrants        
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation        
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances     33,260 0
Mark-to-market adjustment of stock warrants     (13,993) 11
Ending balance 29 40 $ 29 $ 40
Private Placement Warrants | Level 3        
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation        
Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]     Expense Expense
Public Warrants        
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation        
Gain from change in fair value of warrant liability $ 5,700 $ 800 $ 14,600 $ (300)